Research on the Treatment of Severe Community-acquired Pneumonia in Children
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The need for glucocorticoid therapy in children with severe community-acquired pneumonia in
the acute phase of the disease remains unclear. The implementation of this study could
provide strong evidence on the need for adjuvant glucose therapy in children with severe
community-acquired pneumonia.